Elpida Therapeutics’ Press Release

Elpida Therapeutics released a press release about acquiring ION283 and advancing this potential therapy. We are fortunate that Terry shared a letter with us earlier in the week.

For more information about the nonprofit biotech company and the license transfer from Ionis, you can read the press release that Elpida Therapeutics sent out here.

Please direct any questions about ION283, Elpida Therapeutics, or the Safety Study to ion283@chelseashope.org.